STOCK TITAN

Denali Therapeutics: T. Rowe Price reports 12.3% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Denali Therapeutics Inc. (DNLI) is the issuer in an amended common-stock ownership report by T. Rowe Price Investment Management, Inc. The investment manager reported 19,634,011 shares, equal to 12.3% of the class, and sole voting power over 18,904,392 shares; it reported sole dispositive power over 19,634,011 shares, with no shared voting or dispositive power. The report identifies September 30, 2026, as the event date and states that its filing is not an admission of beneficial ownership, which the investment manager expressly denies.

Aggregate beneficial ownership 19,634,011 shares Reported by T. Rowe Price Investment Management, Inc.; event date September 30, 2026.
Percentage of class 12.3% Reported for T. Rowe Price Investment Management, Inc.
Sole voting power 18,904,392 shares Reported for T. Rowe Price Investment Management, Inc.
Sole dispositive power 19,634,011 shares Reported for T. Rowe Price Investment Management, Inc.
beneficially owned regulatory
"Amount beneficially owned: 19,634,011"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
dispositive power regulatory
"Sole power to dispose or to direct the disposition of: 19,634,011"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DNLI shares did T. Rowe Price Investment Management report?

T. Rowe Price Investment Management, Inc. reported aggregate beneficial ownership of 19,634,011 Denali common shares, representing 12.3% of the class.

What voting and dispositive power did T. Rowe Price report over DNLI shares?

It reported sole voting power over 18,904,392 shares and sole dispositive power over 19,634,011 shares; shared voting and dispositive power were each zero.

Did T. Rowe Price Investment Management affirm beneficial ownership of DNLI shares?

No. T. Rowe Price Investment Management stated that the report is not an admission that it is the beneficial owner and expressly denied beneficial ownership of the securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





24823R105

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



T. Rowe Price Investment Management, Inc.
Signature:Ellen York
Name/Title:Vice President
Date:11/16/2026

Keep reading